Activated CaMKII plays an important role in the development of abnormal vascular dysfunction in diabetes, including diabetic retinopathy; in fact, autocamtide-2-related inhibitory peptide, a potent inhibitor of CaMKII, prevents vascular leakage in diabetic mice [53,54,55]. Here, CAMK2G is linked to diabetic retinopathy.